Compound Evidence File
#EC-2026-0590
Testosterone Phenylpropionate Raw
Filed under Raw Materials. The bureau holds 117 laboratory returns for this compound from 43 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
43 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Jan 2026 | 8 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Dec 2025 | 15 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Mar 2026 | 27 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Mar 2026 | 21 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 12 Aug 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Apr 2026 | 12 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Jan 2026 | 11 Mar 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Apr 2026 | 22 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 8 Jun 2026 | 2 Jul 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Feb 2026 | 16 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Aug 2026 | 19 Aug 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 9 Nov 2025 | 16 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Jan 2026 | 26 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Jul 2026 | 9 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Jan 2026 | 11 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 18 May 2026 | 7 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Jun 2026 | 24 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Jan 2026 | 4 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 9.9 | 9 Mar 2026 | 15 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Apr 2026 | 2 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 9.9 | 14 Feb 2026 | 19 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 9.0 | 8.4 | 9.3 | 21 May 2026 | 21 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 1 | 8.9 | 8.9 | 8.9 | 7 May 2025 | 7 May 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.8 | 7.9 | 9.9 | 24 May 2026 | 24 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 8.8 | 8.8 | 8.8 | 27 Feb 2025 | 27 Feb 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 8.6 | 8.6 | 8.6 | 3 Jul 2025 | 3 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.4 | 7.1 | 9.4 | 23 May 2026 | 23 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 8.4 | 8.4 | 8.4 | 7 May 2025 | 7 May 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.3 | 6.9 | 9.2 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 7.8 | 6.4 | 9.3 | 25 May 2026 | 25 May 2026 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 | 8 Jul 2025 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 7.7 | 7.7 | 7.7 | 27 Feb 2025 | 27 Feb 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 6.8 | 6.6 | 6.9 | 11 Jun 2025 | 24 May 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 2 | 6.8 | 6.0 | 7.5 | 28 Mar 2025 | 17 May 2026 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 6.1 | 6.1 | 6.1 | 16 Mar 2025 | 16 Mar 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 5.6 | 4.3 | 6.8 | 6 May 2025 | 26 Jan 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 2 | 5.5 | 5.4 | 5.6 | 16 Mar 2025 | 23 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 5.4 | 5.4 | 5.4 | 3 Jun 2025 | 3 Jun 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.2 | 0.2 | 0.2 | 8 Jul 2025 | 8 Jul 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.1 | 0.1 | 0.1 | 14 Jan 2025 | 14 Jan 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
Open any subject to view the batch-level evidence for Testosterone Phenylpropionate Raw alone.